Bli medlem
Bli medlem

Du är här


PEPTONIC Medical AB: Peptonic Medical announces appointment of Mikael Svensson as General Manager USA

Stockholm, Sweden February 23, 2021 - Peptonic Medical AB (publ) (`Peptonic' or `the company') has announced the appointment of Mikael Svensson, a strategic and operational leader, to the position of General Manager USA.

Mr. Svensson holds a proven track record of successful business and operational leadership roles in North America and globally. He joins Peptonic from Good Science Beauty where he served as Chief Operations Officer. Prior Mr. Svensson have held international leadership roles with companies such as Johnson & Johnson, Q-Med and Merz.

"We are extremely pleased to welcome Mikael Svensson to Peptonic Medical to lead our US commercialization activities as we continue the rapid growth of our company", said Johan Inborr, CEO of Peptonic. "Mikael's strategic perspectives and operational experience from his 15 years in the US will be extremely useful as we leverage our innovative products and expand our footprint in the US."

Mr. Svensson stated, "I am excited to join an organization that is committed to developing safe and effective products for the $19 billion women's intimate health market, and at a time they are experiencing fast growth and great momentum. I strongly believe in the opportunity for the VagiVital® and Lunette® brands in the US and I am privileged to lead the US commercial development going forward."

For more information, please contact;

Johan Inborr, CEO

Mobile: +46 708 853 893


This information is information that Peptonic Medical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 23rd February, 2021.

Författare Cision

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.